27.06.2022 - Industry leader brings deep expertise in international drug development, strategic leadership, and corporate partnering for biopharmaceutical companiesDURHAM, N.C., June 27, 2022 (GLOBE NEWSWIRE) - Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage .
Industry leader brings deep expertise in international drug development, strategic leadership, and corporate partnering for biopharmaceutical companies.
Cumulus Oncology appoints chief business officer and 2 NXDs scottishbusinessnews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scottishbusinessnews.net Daily Mail and Mail on Sunday newspapers.